Literature DB >> 6363499

Behavioral effects of vagotomy in humans.

J G Kral.   

Abstract

Animal experiments and clinical observations have demonstrated significant effects of vagotomy on body weight. Weight loss or inability to regain are partly due to impaired motility and secretomotor activity of the vagus nerve causing disturbances in digestion which, however, are not sufficient to explain most of the weight deficit after vagotomy in animals or morbidly obese patients. The body weight deficit is also due to reduced caloric intake with changes in the quantity and quality of food and liquid intake, the latter accounting for more than one-third of the total reduction in caloric intake. Obese patients have consistent decreases in hunger ratings after vagotomy and also reveal changed hedonic ratings and estimations of taste intensity. Validation of vagotomy studies requires tests of vagal integrity to confirm the completeness of the surgery and rule out regeneration of nerve tissue or recruitment of function. Tests of completeness of vagotomy are difficult to perform and evaluate in morbidly obese patients due to insulin resistance. The finding of an inadequate gastric acid response to insulin hypoglycemia implies a defect hypothalamic response to hypoglycemic stress in these patients. A new postoperative test of completeness of vagotomy based on disrupted drinking after intravenous hypertonic saline challenge is introduced as an attractive alternative to the potentially hazardous insulin test.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6363499     DOI: 10.1016/0165-1838(83)90147-9

Source DB:  PubMed          Journal:  J Auton Nerv Syst        ISSN: 0165-1838


  4 in total

Review 1.  Options for the management of obesity.

Authors:  P L Beales; P G Kopelman
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

2.  Vagal nerve function in obesity: therapeutic implications.

Authors:  John G Kral; Wencesley Paez; Bruce M Wolfe
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

Review 3.  Ghrelin: integrative neuroendocrine peptide in health and disease.

Authors:  James T Wu; John G Kral
Journal:  Ann Surg       Date:  2004-04       Impact factor: 12.969

4.  Characterisation of oral and i.v. glucose handling in truncally vagotomised subjects with pyloroplasty.

Authors:  Astrid Plamboeck; Simon Veedfald; Carolyn F Deacon; Bolette Hartmann; André Wettergren; Lars B Svendsen; Søren Meisner; Claus Hovendal; Filip K Knop; Tina Vilsbøll; Jens J Holst
Journal:  Eur J Endocrinol       Date:  2013-07-06       Impact factor: 6.664

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.